Wong L, Yamasaki G, Johnson R J, Friedman S L
University of California, San Francisco Liver Center Laboratory 94110.
J Clin Invest. 1994 Oct;94(4):1563-9. doi: 10.1172/JCI117497.
A consistent response to liver injury is the activation of resident mesenchymal cells known as lipocytes (Ito, fat-storing cells) into a proliferating cell type. In cultured lipocytes, platelet-derived growth factor (PDGF) is the most potent proliferative cytokine, but requires the activation-dependent expression of its receptor protein (Friedman, S. L., and M. J. P. Arthur. 1989. J. Clin. Invest. 84:1780-1785); the role of PDGF receptor (PDGFR) in liver injury is unknown. We have examined PDGFR gene expression in freshly isolated lipocytes during liver injury and correlated these findings with a culture model of cellular activation. Whereas lipocytes from normal rats had no detectable transcript for the beta-PDGFR subunit, this mRNA was induced within 1 h after a dose of carbon tetrachloride (CCl4). In contrast, alpha subunit mRNA was detected in normal cells, but was unchanged after liver injury. Similar results were observed in lipocytes from bile duct-obstructed rats, although beta-PDGFR induction was less marked. By immunoblot, induction of beta-PDGFR protein in lipocytes isolated from CCl4-treated animals correlated with mRNA increases. In contrast to lipocytes, endothelial cells from normal liver expressed low levels of alpha- and beta-receptor subunit mRNA, which did not increase with injury. Using a beta-PDGFR antibody, receptor protein could be identified within fibrotic septa in CCl4-treated animals in regions where cells expressed proliferating cell nuclear antigen (PCNA). In cultured lipocytes activated by growth on uncoated plastic, beta-PDGFR transcripts appeared within 3 d after plating, which coincided with the onset of cellular proliferation. In contrast, quiescent cells in suspension culture had no detectable beta-PDGFR mRNA. These results indicate that beta-PDGF receptor induction by lipocytes is an early event during hepatic injury in vivo and in primary culture.
对肝损伤的一种持续反应是,被称为脂肪细胞(伊托细胞、贮脂细胞)的肝内间充质细胞被激活,转变为增殖细胞类型。在培养的脂肪细胞中,血小板衍生生长因子(PDGF)是最有效的增殖细胞因子,但需要其受体蛋白的激活依赖性表达(弗里德曼,S.L.,和M.J.P.亚瑟。1989年。《临床研究杂志》84:1780 - 1785);PDGF受体(PDGFR)在肝损伤中的作用尚不清楚。我们检测了肝损伤期间新鲜分离的脂肪细胞中PDGFR基因的表达,并将这些发现与细胞激活的培养模型相关联。来自正常大鼠的脂肪细胞未检测到β - PDGFR亚基的转录本,但在给予四氯化碳(CCl4)剂量后1小时内该mRNA被诱导产生。相比之下,α亚基mRNA在正常细胞中可检测到,但肝损伤后未发生变化。在胆管阻塞大鼠来源的脂肪细胞中也观察到了类似结果,尽管β - PDGFR的诱导不太明显。通过免疫印迹法,从CCl4处理动物分离的脂肪细胞中β - PDGFR蛋白的诱导与mRNA增加相关。与脂肪细胞不同,正常肝脏的内皮细胞表达低水平的α和β受体亚基mRNA,损伤后不增加。使用β - PDGFR抗体,在CCl4处理动物的纤维化间隔中,在表达增殖细胞核抗原(PCNA)的细胞区域可鉴定出受体蛋白。在未包被塑料上生长而被激活的培养脂肪细胞中,接种后3天内出现β - PDGFR转录本,这与细胞增殖的开始相吻合。相比之下,悬浮培养的静止细胞未检测到β - PDGFR mRNA。这些结果表明,脂肪细胞诱导β - PDGF受体是体内和原代培养肝损伤期间的早期事件。